Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30(+) Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

Wang Di; Xiao Yi; Li Chunrui; Wang Na; Huang Liang; Zhang Yicheng; Zhang Tongcun; Zhou Jianfeng

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30(+) Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

【24h】

Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30(+) Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

机译：抗CD30嵌合抗原受体T细胞治疗CD30（+）复发/难治性霍奇金淋巴瘤和促进式大细胞淋巴瘤患者

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共2页
作者
Wang Di; Xiao Yi; Li Chunrui; Wang Na; Huang Liang; Zhang Yicheng; Zhang Tongcun; Zhou Jianfeng;
展开▼
作者单位

Huazhong Univ Sci &

Technol Tongji Med Coll Tongji Hosp Dept Hematol Wuhan Hubei Peoples R;

Huazhong Univ Sci &

Technol Tongji Med Coll Tongji Hosp Dept Hematol Wuhan Hubei Peoples R;

Huazhong Univ Sci &

Technol Tongji Med Coll Tongji Hosp Dept Hematol Wuhan Hubei Peoples R;

Huazhong Univ Sci &

Technol Tongji Med Coll Tongji Hosp Dept Hematol Wuhan Hubei Peoples R;

Huazhong Univ Sci &

Technol Tongji Med Coll Tongji Hosp Dept Hematol Wuhan Hubei Peoples R;

Huazhong Univ Sci &

Technol Tongji Med Coll Tongji Hosp Dept Hematol Wuhan Hubei Peoples R;

Wuhan Univ Sci &

Technol Wuhan Hubei Peoples R China;

Huazhong Univ Sci &

Technol Tongji Med Coll Tongji Hosp Dept Hematol Wuhan Hubei Peoples R;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30(+) Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients [J] . Wang Di, Xiao Yi, Li Chunrui, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：抗CD30嵌合抗原受体T细胞治疗CD30（+）复发/难治性霍奇金淋巴瘤和促进式大细胞淋巴瘤患者
2. Sequential Anti-CD19 Directed Chimeric Antigen Receptor Modified T-Cell Therapy (CART19) and PD-1 Blockade with Pembrolizumab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas [J] . Chong Elise A., Svoboda Jakub, Nasta Sunita Dwivedy, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：顺序抗CD19定向嵌合抗原受体修饰的T细胞疗法（CART19）和PD-1与PEMBROLIZUAB的患者复发或难治性B细胞非霍奇金淋巴瘤患者
3. Tandem Induction Radiation and Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma [J] . Arscott W. T., Miller D., Jones J. A., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：复发或难治性非霍奇金淋巴瘤患者的串联感应辐射和嵌合抗原受体T细胞疗法
4. Functional characterization of ubiquitination profile changes induced by oncogenic protein NPM-ALK in ALK~(+) anaplastic large cell lymphoma cells [C] . Fang Wu, Peng Wang, Raymond Lai, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：致癌蛋白NPM-ALK诱导ubiquitination曲线变化的功能表征Ala1（+）促进大细胞淋巴瘤细胞
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients [O] . D. Wang, C. Zeng, B. Xu, 2020

机译：抗CD30嵌合抗原受体T细胞疗法用于复发/难治性CD30 +淋巴瘤患者
7. Tandem Induction Radiation and Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma [O] . W.T. Arscott, D. Miller, J.A. Jones, 2018

机译：复发或难治性非霍奇金淋巴瘤患者的串联感应辐射和嵌合抗原受体T细胞疗法

Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30(+) Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

著录项

相似文献

相关主题

期刊订阅